- Issuer ticker
-
ZYME
- Reported as of
-
10 Aug 2025
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
3
- Accepted by SEC
-
12 Aug 2025, 20:00:09 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Daniel Dex, Attorney-in-Fact
Key filing fact
Robert E. Landry filed Form 3 for Zymeworks Inc. (ZYME) on 12 Aug 2025.
Key facts
- This page summarizes Robert E. Landry's Form 3 filing for Zymeworks Inc. (ZYME).
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Aug 2025, 20:00.
Change
- Previous filing in this sequence was filed on 14 May 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
Ownership activity is grounded in SEC Form 3 disclosures.
View source filing
Reporting Owners (1)
CIK 0001585160
Primary reporting owner
Landry Robert E
- Relationship
-
Director
- Address
- C/O ZYMEWORKS INC., 108 PATRIOT DRIVE, SUITE A, MIDDLETOWN
- Signature
- /s/ Daniel Dex, Attorney-in-Fact
- Signature date
- 12 Aug 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ZYME
holding
No securities are beneficially owned
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 0
- Date
- 10 Aug 2025
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ZYME
holding
Derivative
No securities are beneficially owned
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- Date
- 10 Aug 2025
- Ownership
- Direct
- Underlying class
- Not applicable
- Underlying amount
- 0
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote
SEC remarks
Exhibit List - Exhibit 24 - Power of Attorney